Share Early, intensive treatment: A year really does make a difference

Copy link

February 18, 2020

Early, intensive treatment: A year really does make a difference

16 minutes

Featuring an interview with Professor Tina Vilsboll.

Rapid achievement of glycaemic targets has been a key goal of treatment in diabetes, but does it matter how quickly we achieve this? Based on guidelines, trial evidence and real-world studies, the answer is a resounding "yes". Tune in to this episode to learn outcome improvements associated with early, intensive therapy, and how to achieve this in your clinic.

References

Davies MJ, et al. Diabetes Care 2018; 41(12):2669-2701

Buse JB, et al. Diabetologia. 2020; 63(2):221-228.

Thomas MC. Adv Chronic Kidney Dis. 2014; 21(3):311-7

Laiteerapong N, et al. Diabetes Care. 2019; 42(3):416-426

Paul SK, et al. Cardiovasc Diabetol. 2015;14:100.

Reaven PD, et al. N Engl J Med 2019; 380:2215-2224

Khunti K, Millar-Jones D. Prim Care Diabetes. 2017;11(1):3-12.

This independent educational activity is supported by an educational grant from Novo Nordisk A/S. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; Novo Nordisk A/S has had no influence on the content of this education.

...more